Stone progression preventable in private practice

Chicago-A private practice setting can be just as successful with renal stone prevention as a larger academic setting, according to research presented at the AUA annual meeting here. And, if treatment is needed later, a patient can be counseled about options following an accurate assessment of the natural progression of stones.

Related Content:

Drug Therapy

Pivotal data for lumasiran in PH1 published in NEJM

Nedosiran explored in primary hyperoxaluria type 3

Enrollment completed in pivotal trial of nedosiran for hyperoxaluria